These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8446259)

  • 1. Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?
    Bellomo R; Atkins RC
    Nephron; 1993; 63(3):249-54. PubMed ID: 8446259
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy.
    Sarasin FP; Schifferli JA
    Kidney Int; 1994 Feb; 45(2):578-85. PubMed ID: 8164448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.
    Zou H; Li Y; Xu G
    BMC Nephrol; 2019 Dec; 20(1):442. PubMed ID: 31791286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.
    Lee T; Biddle AK; Lionaki S; Derebail VK; Barbour SJ; Tannous S; Hladunewich MA; Hu Y; Poulton CJ; Mahoney SL; Charles Jennette J; Hogan SL; Falk RJ; Cattran DC; Reich HN; Nachman PH
    Kidney Int; 2014 Jun; 85(6):1412-20. PubMed ID: 24336031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary polycythaemia associated with idiopathic membranous nephropathy.
    Khan IH; Simpson JG; MacLeod AM; Catto GR
    Nephron; 1993; 64(2):310-1. PubMed ID: 8321368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombo-prevention in membranous nephropathy: a new tool for decision making?
    Glassock RJ
    Kidney Int; 2014 Jun; 85(6):1265-6. PubMed ID: 24875548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous Thromboembolism in Primary Nephrotic Syndrome - Is the Risk High Enough to Justify Prophylactic Anticoagulation?
    Rankin AJ; McQuarrie EP; Fox JG; Geddes CC; MacKinnon B;
    Nephron; 2017; 135(1):39-45. PubMed ID: 27669572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism and membranous nephropathy: so what's new?
    Radhakrishnan J
    Clin J Am Soc Nephrol; 2012 Jan; 7(1):3-4. PubMed ID: 22173862
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term complications of membranous nephropathy.
    Barbour S; Reich H; Cattran D
    Contrib Nephrol; 2013; 181():143-51. PubMed ID: 23689576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple thromboembolic events in membranous nephropathy.
    Chen HW; Chen JS
    Intern Med; 2011; 50(6):655. PubMed ID: 21422698
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombotic complications in childhood-onset idiopathic membranous nephropathy.
    Louis CU; Morgenstern BZ; Butani L
    Pediatr Nephrol; 2003 Dec; 18(12):1298-300. PubMed ID: 14586672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased genetic risk of hypertension in immunoglobulin A nephropathy but not in membranous nephropathy.
    Autuly V; Laruelle E; Benziane A; Ang KS; Cam G; Ramée MP; Simon P
    J Hypertens Suppl; 1991 Dec; 9(6):S220-1. PubMed ID: 1818952
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic inferior venacava thrombosis in membranous nephropathy.
    Prabahar MR; Jayakumar M; Soundararajan P
    Nephrol Dial Transplant; 2008 Jul; 23(7):2422-3. PubMed ID: 18456677
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of membranous nephropathy with familial resistance to activated protein C.
    Montinaro V; Coccheri S; Palareti G; Legnani C; Lunghi B; Bernardi F; Schena FP
    Nephrol Dial Transplant; 1995 Nov; 10(11):2133-6. PubMed ID: 8643185
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexisting Membranous Nephropathy and IgA Nephropathy.
    Nishida M; Kato R; Hamaoka K
    Fetal Pediatr Pathol; 2015; 34(6):351-4. PubMed ID: 26418809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Recklinghausen neurofibromatosis associated with membranous nephropathy.
    Kokubo T; Hiki Y; Horii A; Kobayashi Y
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):951-4. PubMed ID: 7933673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membranous nephropathy and crescentic glomerulonephritis].
    Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
    Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism and the role of anticoagulation in the Fontan patient.
    Jacobs ML; Pourmoghadam KK
    Pediatr Cardiol; 2007; 28(6):457-64. PubMed ID: 17762953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on "Concurrent Focal Segmental Glomerulosclerosis and Membranous Nephropathy" by Amenta et al.
    Van Damme B; Tardanico R; Vanrenterghem V; Desmet V
    Clin Nephrol; 1990 Mar; 33(3):152-3. PubMed ID: 2323114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.